Heart Care, Connected.
Prolaio (prolaio.com) earns a Brand Analyzer score of 69 out of 100, placing it in the Developing tier among Healthcare brands, SaaS brands. Among 2305 Healthcare brands analyzed, Prolaio ranks in the 56th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 100/100, Digital Presence 82/100, Visual Identity 85/100, Messaging Clarity 95/100, Trust Foundation 70/100, AI Discoverability 70/100, Brand Authority 13/100.
Prolaio is a healthcare SaaS company focused on cardiovascular care. It operates a clinical intelligence platform that enables continuous, predictive, and shareable heart data collection, connecting patients, care teams, and clinical researchers. The platform aims to replace episodic, hospital-based cardiac monitoring with high-density data insights, supporting both day-to-day patient management and the acceleration of new cardiovascular therapies through clinical research.
| Brand Name | Prolaio |
|---|---|
| Domain | prolaio.com |
| Industry | Healthcare, SaaS |
| Main Competitors | iRhythm Technologies, Medtronic (83/100), AliveCor, BioTelemetry, Preventice Solutions, Philips Healthcare |
Moz Domain Authority 14/100 vs category average 29 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #3,395,477 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Unlocking continuous, predictive and shareable heart data to liberate patients from hospital-based reactive care and accelerate every new therapy." (Meta description: 19 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Instagram, LinkedIn, YouTube, GitHub; no detected presence on Facebook, X (Twitter) - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Prolaio scores 16/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Prolaio has a weak AI-visibility profile at 16/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (42/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #3,395,477 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 14/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Prolaio's main competitors include iRhythm Technologies, Medtronic (83/100), AliveCor, BioTelemetry, Preventice Solutions. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Prolaio official site
Prolaio and Medtronic are competitors in Healthcare. Brand Analyzer scores Prolaio at 69/100 and Medtronic at 83/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Prolaio official site
Popular alternatives to Prolaio include iRhythm Technologies, Medtronic (83/100), AliveCor, BioTelemetry, Preventice Solutions. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Prolaio official site
Prolaio has low AI-search visibility, scoring 16/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 17, recommendation 42). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Prolaio official site
Prolaio is a healthcare SaaS company that operates a clinical intelligence platform for cardiovascular care. It is designed to bridge day-to-day patient care and cutting-edge clinical research by uniting patients, care teams, and researchers on a single secure platform. Its focus is on enabling continuous, predictive, and shareable cardiac data to move patients away from reactive, hospital-based monitoring toward more proactive, data-driven care and to accelerate the development of new cardiovascular therapies.
Sources: Prolaio official site
Prolaio provides a clinical intelligence platform that collects and delivers continuous, predictive, and shareable heart data. It replaces traditional episodic cardiac monitoring with high-density data insights, allowing patients, healthcare providers, and clinical researchers to access and act on cardiac information in real time. By connecting all three groups on a secure platform, Prolaio aims to improve patient outcomes, reduce dependence on hospital-based reactive care, and speed up the development and validation of new cardiovascular therapies.
Sources: Prolaio official site
Prolaio scores 42/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Prolaio official site
Prolaio's platform is designed for three primary audiences: patients who require cardiovascular monitoring, healthcare providers and care teams managing those patients, and clinical researchers working to develop new cardiovascular therapies. The platform is built to serve all three groups simultaneously on a shared, secure infrastructure, enabling collaboration across patient care and clinical research in the cardiovascular space.
Sources: Prolaio official site
Prolaio can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Prolaio official site
Based on available information, Prolaio offers a clinical intelligence platform for cardiovascular care. This platform is described as a secure, unified environment for patients, healthcare providers, and clinical researchers. Its core capabilities include continuous cardiac monitoring, predictive heart data analytics, and shareable data infrastructure intended to support both clinical care and the acceleration of new cardiovascular therapies. Specific product names, pricing tiers, or detailed feature lists are not available in the known facts.
Sources: Prolaio official site
Prolaio is known for its clinical intelligence platform that unlocks continuous, predictive, and shareable heart data. It is recognized for its positioning at the intersection of patient care and clinical research in cardiovascular medicine, specifically for replacing episodic monitoring with high-density cardiac data insights. The platform's ability to unite patients, care teams, and researchers on one secure system is a distinguishing characteristic noted in its value proposition.
Sources: Prolaio official site
Ranked closest to Prolaio: PRIA Healthcare (69/100), PayerWatch (69/100), Psychē Systems (69/100), Quris AI (69/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).